[Therapeutic effects of RNA interference targeting HIF-1 alpha gene on human osteosarcoma]

Qiang Wu1, Shu-Hua Yang, Shu-Nan Ye

  • 1Department of Orthopaedic, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Zhonghua Yi Xue Za Zhi
|April 28, 2005
PubMed
Abstract

Insights

Small hairpin RNA (shRNA) targeting the HIF-1alpha gene effectively inhibits osteosarcoma growth by blocking hypoxia pathways. This study demonstrates significant reductions in tumor growth and increased apoptosis in vitro and in vivo.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Therapy

Context:

  • Osteosarcoma is a primary bone malignancy with limited treatment options.
  • Hypoxia-inducible factor 1-alpha (HIF-1alpha) is a key regulator in tumor development and progression.
  • Targeting HIF-1alpha presents a potential therapeutic strategy for osteosarcoma.

Purpose:

  • To investigate the inhibitory effect of small hairpin RNA (shRNA) targeting the HIF-1alpha gene on osteosarcoma growth.
  • To evaluate the efficacy of shRNA-mediated HIF-1alpha inhibition in vitro and in vivo models.

Summary:

  • A shRNA eukaryotic expression vector (pSilencer-HIF) targeting HIF-1alpha was constructed and transfected into SaOS-2 osteosarcoma cells.
  • Transfection significantly inhibited HIF-1alpha expression (90%), reduced cell growth, and induced apoptosis under hypoxic conditions.
  • In vivo studies showed that pSilencer-HIF transfection significantly slowed xenograft tumor growth and increased necrosis in mice.

Impact:

  • shRNA targeting HIF-1alpha effectively blocks the hypoxia transduction pathway.
  • This approach demonstrates significant inhibition of osteosarcoma cell growth and tumor formation.
  • Provides a potential gene therapy strategy for osteosarcoma treatment.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...